Literature DB >> 17018380

Incidence and complete molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Guangxi Zhuang autonomous region of southern China: description of four novel mutations.

Tizhen Yan1, Ren Cai, OiuHua Mo, DongLin Zhu, Hong Ouyang, Lihua Huang, Mingguang Zhao, Fen Huang, Liyan Li, Xin Liang, Xiangmin Xu.   

Abstract

BACKGROUND AND OBJECTIVES: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human metabolic disorder in southern China. We investigated the incidence and distribution of mutations, the molecular pathology of affected females and the haplotype association with G6PD deficiency in patients from the Guangxi region. DESIGN AND METHODS: A population-based molecular analysis combining phenotypic screening and genotypic detection using both multiplex primer extension/denaturing high performance liquid chromatography assay and DNA sequence analysis were performed in a total of 4,704 individuals.
RESULTS: The mutation frequency of male G6PD-deficient individuals was observed to be 7.43%. Twenty-seven genotypes from 361 individuals were found. Statistical analysis showed that there were significant differences in both the percentages of methemoglobin and the G6PD/6PGD ratio between heterozygote and hemizygote in males and between heterozygote and homozygote in females. However, no statistically significance was seen between hemizyotes and homozygotes. The mutation profile showed that five mutations, G6PD Kaiping(1388A), G6PD Canton(1376T), G6PD Gaohe(95G), Chinese-5(1024T)and G6PD Viangchan(817A), are the most common in the area, accounting for 85% of the G6PD-deficient alleles. Ten rare mutations were detected in approximately 4% of the mutant chromosomes. Four novel mutations were found: G6PD Liuzhou(442A), G6PD Nanning(703T), G6PD Laibin(1414C,) and G6PD Hechi(202A/817A). In addition, two other rare mutations, c.196T-->A and c.202 G-->A, were detected for the first time in Chinese patients. A single dominant haplotype (- - + - -) was observed in 94.0% of 182 deficient chromosomes. INTERPRETATION AND
CONCLUSIONS: Our protocol could be used to extend the knowledge of molecular defects of G6PD gene in different geographical areas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018380

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  21 in total

1.  Glucose-6-phosphate dehydrogenase and NADPH oxidase 4 control STAT3 activity in melanoma cells through a pathway involving reactive oxygen species, c-SRC and SHP2.

Authors:  Tianchi Cai; Yingmin Kuang; Chunhua Zhang; Zheng Zhang; Long Chen; Bo Li; Yuqian Li; Yanling Wang; Huixin Yang; Qiaoqiao Han; Yuechun Zhu
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

2.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.

Authors:  M V Relling; E M McDonagh; T Chang; K E Caudle; H L McLeod; C E Haidar; T Klein; L Luzzatto
Journal:  Clin Pharmacol Ther       Date:  2014-05-02       Impact factor: 6.875

3.  Rapid and reliable detection of glucose-6-phosphate dehydrogenase (G6PD) gene mutations in Han Chinese using high-resolution melting analysis.

Authors:  Jing-bin Yan; Hong-ping Xu; Can Xiong; Zhao-rui Ren; Guo-li Tian; Fanyi Zeng; Shu-zhen Huang
Journal:  J Mol Diagn       Date:  2010-03-04       Impact factor: 5.568

4.  PharmGKB summary: very important pharmacogene information for G6PD.

Authors:  Ellen M McDonagh; Caroline F Thorn; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-03       Impact factor: 2.089

5.  Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar.

Authors:  Issarang Nuchprayoon; Chalisa Louicharoen; Warisa Charoenvej
Journal:  J Hum Genet       Date:  2007-11-28       Impact factor: 3.172

6.  Molecular epidemiological investigation of G6PD deficiency by a gene chip among Chinese Hakka of southern Jiangxi province.

Authors:  Rong Hu; Min Lin; Jun Ye; Bao-Ping Zheng; Li-Xia Jiang; Juan-Juan Zhu; Xiao-Hong Chen; Mi Lai; Tian-Yu Zhong
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

7.  A novel point mutation in a class IV glucose-6-phosphate dehydrogenase variant (G6PD São Paulo) and polymorphic G6PD variants in São Paulo State, Brazil.

Authors:  Raimundo Antonio G Oliveira; Marilena Oshiro; Mario H Hirata; Rosario D C Hirata; Georgina S Ribeiro; Tereza M D Medeiros; Orlando C de O Barretto
Journal:  Genet Mol Biol       Date:  2009-06-01       Impact factor: 1.771

8.  Large cohort screening of G6PD deficiency and the mutational spectrum in the Dongguan District in Southern China.

Authors:  Qi Peng; Siping Li; Keze Ma; Wenrui Li; Qiang Ma; Xiaoguang He; Yuejing He; Ting He; Xiaomei Lu
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

9.  Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border.

Authors:  Germana Bancone; Cindy S Chu; Raweewan Somsakchaicharoen; Nongnud Chowwiwat; Daniel M Parker; Prakaykaew Charunwatthana; Nicholas J White; François H Nosten
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

10.  Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.

Authors:  Sócrates Herrera Valencia; Iván Darío Ocampo; María Isabel Arce-Plata; Judith Recht; Myriam Arévalo-Herrera
Journal:  Malar J       Date:  2016-05-26       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.